PK/PD Study of U-500 Regular Insulin

NCT02148250 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes
Insulin Resistance
High Insulin Requirements

Interventions

DRUG: U-500 insulin, 100 syringe units
DRUG: U-500 insulin, 200 syringe units

Sponsor

University of Minnesota

Collaborators

[object Object]